Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia

2 Visualizzazioni
administrator
administrator
08/04/23

In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.

  • Categoria

Mostra di più

0 Commenti Ordina per

Nessun commento trovato

Commenti su Facebook

Avanti il prossimo